Impact of tobacco smoke and nicotine exposure on lung development

Research output: Contribution to journalArticle

Abstract

Tobacco smoke and nicotine exposure during prenatal and postnatal life can impair lung development, alter the immune response to viral infections, and increase the prevalence of wheezing during childhood. The following review examines recent discoveries in the fields of lung development and tobacco and nicotine exposure, emphasizing studies published within the last 5 years. In utero tobacco and nicotine exposure remains common, occurring in approximately 10% of pregnancies within the United States. Exposed neonates are at increased risk for diminished lung function, altered central and peripheral respiratory chemoreception, and increased asthma symptoms throughout childhood. Recently, genomic and epigenetic risk factors, such as alterations in DNA methylation, have been identified that may influence the risk for long-term disease. This review examines the impact of prenatal tobacco and nicotine exposure on lung development with a particular focus on nicotinic acetylcholine receptors. In addition, this review examines the role of prenatal and postnatal tobacco smoke and nicotine exposure and its association with augmenting infection risk, skewing the immune response toward a T-helper type 2 bias and increasing risk for developing an allergic phenotype and asthmalike symptoms during childhood. Finally, this review outlines the respiratory morbidities associated with childhood secondhand smoke and nicotine exposure and examines genetic and epigenetic modifiers that may influence respiratory health in infants and children exposed to in utero or postnatal tobacco smoke.

Original languageEnglish (US)
Pages (from-to)552-561
Number of pages10
JournalChest
Volume149
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Nicotine
Smoke
Tobacco
Lung
Epigenomics
Tobacco Smoke Pollution
Respiratory Sounds
Nicotinic Receptors
Virus Diseases
DNA Methylation
Asthma
Morbidity
Phenotype
Pregnancy
Infection

Keywords

  • Lung development
  • Secondhand smoke exposure
  • Thirdhand smoke exposure
  • Tobacco smoke

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Impact of tobacco smoke and nicotine exposure on lung development. / Gibbs, Kevin; Collaco, Michael; McGrath-Morrow, Sharon A.

In: Chest, Vol. 149, No. 2, 01.02.2016, p. 552-561.

Research output: Contribution to journalArticle

@article{661e19ed31c545d3b184bd4c28b1b064,
title = "Impact of tobacco smoke and nicotine exposure on lung development",
abstract = "Tobacco smoke and nicotine exposure during prenatal and postnatal life can impair lung development, alter the immune response to viral infections, and increase the prevalence of wheezing during childhood. The following review examines recent discoveries in the fields of lung development and tobacco and nicotine exposure, emphasizing studies published within the last 5 years. In utero tobacco and nicotine exposure remains common, occurring in approximately 10{\%} of pregnancies within the United States. Exposed neonates are at increased risk for diminished lung function, altered central and peripheral respiratory chemoreception, and increased asthma symptoms throughout childhood. Recently, genomic and epigenetic risk factors, such as alterations in DNA methylation, have been identified that may influence the risk for long-term disease. This review examines the impact of prenatal tobacco and nicotine exposure on lung development with a particular focus on nicotinic acetylcholine receptors. In addition, this review examines the role of prenatal and postnatal tobacco smoke and nicotine exposure and its association with augmenting infection risk, skewing the immune response toward a T-helper type 2 bias and increasing risk for developing an allergic phenotype and asthmalike symptoms during childhood. Finally, this review outlines the respiratory morbidities associated with childhood secondhand smoke and nicotine exposure and examines genetic and epigenetic modifiers that may influence respiratory health in infants and children exposed to in utero or postnatal tobacco smoke.",
keywords = "Lung development, Secondhand smoke exposure, Thirdhand smoke exposure, Tobacco smoke",
author = "Kevin Gibbs and Michael Collaco and McGrath-Morrow, {Sharon A}",
year = "2016",
month = "2",
day = "1",
doi = "10.1378/chest.15-1858",
language = "English (US)",
volume = "149",
pages = "552--561",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "2",

}

TY - JOUR

T1 - Impact of tobacco smoke and nicotine exposure on lung development

AU - Gibbs, Kevin

AU - Collaco, Michael

AU - McGrath-Morrow, Sharon A

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Tobacco smoke and nicotine exposure during prenatal and postnatal life can impair lung development, alter the immune response to viral infections, and increase the prevalence of wheezing during childhood. The following review examines recent discoveries in the fields of lung development and tobacco and nicotine exposure, emphasizing studies published within the last 5 years. In utero tobacco and nicotine exposure remains common, occurring in approximately 10% of pregnancies within the United States. Exposed neonates are at increased risk for diminished lung function, altered central and peripheral respiratory chemoreception, and increased asthma symptoms throughout childhood. Recently, genomic and epigenetic risk factors, such as alterations in DNA methylation, have been identified that may influence the risk for long-term disease. This review examines the impact of prenatal tobacco and nicotine exposure on lung development with a particular focus on nicotinic acetylcholine receptors. In addition, this review examines the role of prenatal and postnatal tobacco smoke and nicotine exposure and its association with augmenting infection risk, skewing the immune response toward a T-helper type 2 bias and increasing risk for developing an allergic phenotype and asthmalike symptoms during childhood. Finally, this review outlines the respiratory morbidities associated with childhood secondhand smoke and nicotine exposure and examines genetic and epigenetic modifiers that may influence respiratory health in infants and children exposed to in utero or postnatal tobacco smoke.

AB - Tobacco smoke and nicotine exposure during prenatal and postnatal life can impair lung development, alter the immune response to viral infections, and increase the prevalence of wheezing during childhood. The following review examines recent discoveries in the fields of lung development and tobacco and nicotine exposure, emphasizing studies published within the last 5 years. In utero tobacco and nicotine exposure remains common, occurring in approximately 10% of pregnancies within the United States. Exposed neonates are at increased risk for diminished lung function, altered central and peripheral respiratory chemoreception, and increased asthma symptoms throughout childhood. Recently, genomic and epigenetic risk factors, such as alterations in DNA methylation, have been identified that may influence the risk for long-term disease. This review examines the impact of prenatal tobacco and nicotine exposure on lung development with a particular focus on nicotinic acetylcholine receptors. In addition, this review examines the role of prenatal and postnatal tobacco smoke and nicotine exposure and its association with augmenting infection risk, skewing the immune response toward a T-helper type 2 bias and increasing risk for developing an allergic phenotype and asthmalike symptoms during childhood. Finally, this review outlines the respiratory morbidities associated with childhood secondhand smoke and nicotine exposure and examines genetic and epigenetic modifiers that may influence respiratory health in infants and children exposed to in utero or postnatal tobacco smoke.

KW - Lung development

KW - Secondhand smoke exposure

KW - Thirdhand smoke exposure

KW - Tobacco smoke

UR - http://www.scopus.com/inward/record.url?scp=84958074493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958074493&partnerID=8YFLogxK

U2 - 10.1378/chest.15-1858

DO - 10.1378/chest.15-1858

M3 - Article

C2 - 26502117

AN - SCOPUS:84958074493

VL - 149

SP - 552

EP - 561

JO - Chest

JF - Chest

SN - 0012-3692

IS - 2

ER -